See also this year's filing and all EDGAR filings for this company.
PDF Report 0001307969_2017_024_Pharma_Inc.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
Graph
Absolute values for 0001307969, 024 Pharma Inc
| xvar | xval | |
|---|---|---|
| 0 | LiabilitiesCurrent | 80,794 |
| 1 | LiabilitiesNoncurrent | 0 |
| 2 | remainder_Liabilities | 0 |
| 3 | AssetsCurrent | 796,548 |
| 4 | PropertyPlantAndEquipmentNet | 43,281 |
| 5 | IntangibleAssets | 0 |
| 6 | AssetsNoncurrent | 0 |
| 7 | remainder_Assets | 0 |
| 8 | CostOfRevenue | 174,426 |
| 9 | SellingGeneralAndAdministrativeExpense | 0 |
| 10 | remainder_Expenses | 284,075 |
| 11 | remainder_Revenues | 1,079,541 |
| 12 | remainder_NetIncome | 0 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Liabilities | 80,794 |
| 1 | Assets | 839,829 |
| 2 | Expenses | 458,501 |
| 3 | Revenues | 1,079,541 |
| 4 | StockholdersEquity | 759,035 |
| 5 | NetIncome | 621,040 |
| 6 | ComprehensiveNetIncome | 621,040 |
| 7 | BaseVar | 1,229,332 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.68 |
| 9 | EconomicCapitalRatio | 2.78 |
Edgar->Model Mapping
Feature Distribution
Change over Time
